- Home
- PROK vs ELVA Comparison
PROK vs ELVA Comparison
Compare PROK & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ELVA
- Stock Information
- Founded
- PROK 2015
- ELVA 1996
- Country
- PROK United States
- ELVA Canada
- Employees
- PROK N/A
- ELVA N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ELVA
- Sector
- PROK Health Care
- ELVA
- Exchange
- PROK Nasdaq
- ELVA Nasdaq
- Market Cap
- PROK 94.9M
- ELVA 103.8M
- IPO Year
- PROK N/A
- ELVA N/A
- Fundamental
- Price
- PROK $0.81
- ELVA $3.04
- Analyst Decision
- PROK Buy
- ELVA Strong Buy
- Analyst Count
- PROK 4
- ELVA 5
- Target Price
- PROK $5.00
- ELVA $6.10
- AVG Volume (30 Days)
- PROK 796.9K
- ELVA 40.9K
- Earning Date
- PROK 05-12-2025
- ELVA 05-14-2025
- Dividend Yield
- PROK N/A
- ELVA N/A
- EPS Growth
- PROK N/A
- ELVA N/A
- EPS
- PROK N/A
- ELVA N/A
- Revenue
- PROK $306,000.00
- ELVA $48,016,000.00
- Revenue This Year
- PROK N/A
- ELVA $55.29
- Revenue Next Year
- PROK N/A
- ELVA $63.69
- P/E Ratio
- PROK N/A
- ELVA N/A
- Revenue Growth
- PROK N/A
- ELVA N/A
- 52 Week Low
- PROK $0.46
- ELVA $1.67
- 52 Week High
- PROK $4.44
- ELVA $3.18
- Technical
- Relative Strength Index (RSI)
- PROK 49.17
- ELVA 71.24
- Support Level
- PROK $0.94
- ELVA $2.66
- Resistance Level
- PROK $0.87
- ELVA $2.85
- Average True Range (ATR)
- PROK 0.11
- ELVA 0.14
- MACD
- PROK 0.01
- ELVA 0.03
- Stochastic Oscillator
- PROK 39.10
- ELVA 90.74
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.